ROSGQ OTC
Rosetta Genomics Ltd.
1W: +0.0%
1M: +0.0%
3M: +9900.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$9M
+11.7% ▲
5Y CAGR: +145.8%
Gross Profit
$2M
-10.1% ▼
Operating Income
-$16M
+0.4% ▲
Net Income
-$16M
+6.4% ▲
EPS (Diluted)
$-9.31
+32.5% ▲
EBITDA
-$15M
+7.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| Revenue | $201K | $405K | $1M | $8M | $9M |
| YoY Growth | +95.1% | +101.5% | +227.7% | +523.1% | +11.7% |
| Cost of Revenue | $258K | $709K | $1M | $6M | $7M |
| Gross Profit | -$57K | -$304K | $17K | $2M | $2M |
| Gross Margin | -28.4% | -75.1% | 1.3% | 24.1% | 19.4% |
| R&D Expenses | $1M | $2M | $2M | $3M | $3M |
| SG&A Expenses | $7M | $11M | $12M | $15M | $14M |
| Operating Expenses | $8M | $13M | $14M | $18M | $17M |
| Operating Income | -$8M | -$13M | -$14M | -$16M | -$16M |
| Operating Margin | -4112.9% | -3295.6% | -1074.0% | -190.1% | -169.6% |
| Interest Expense | $2M | $15K | $39K | $48K | $43K |
| Income Before Tax | -$11M | -$13M | -$15M | -$17M | -$16M |
| Tax Expense | $0 | $0 | $15K | $19K | -$34K |
| Net Income | -$10M | -$13M | -$15M | -$17M | -$16M |
| Net Margin | -5202.5% | -3184.4% | -1094.6% | -209.8% | -175.8% |
| EPS (Diluted) | $-28.20 | $-16.08 | $-15.51 | $-13.79 | $-9.31 |
| EBITDA | -$8M | -$13M | -$14M | -$17M | -$15M |
| Shares Outstanding | 370704 | 799495 | 936657 | 1M | 2M |